METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) TESTING SYSTEMS MARKET ANALYSIS

Market News

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market: Key Developments

On May 17, 2023, Roche Information Solutions India Pvt Ltd, a developing innovative solutions to help labs and clinicians, announced that it is showcasing innovative laboratory solutions and digital diagnostics through- "Innovation Past, Present and Future" at this year’s WorldLab-EuroMedLab 2023 in Rome, Italy, 21-25 May. Attendees have the opportunity to experience first-hand Roche’s latest technological advancements in lab automation, serum work area, molecular and point of care solutions.

In October 2020, 3M, is medical equipment company, expanded Surgical Portfolio with PREVENA RESTOR AXIO FORM Incision Management System is reduce edema, its help to remove infectious material, stabilize the incision, and reduce the time required for recovery.

In January 2020, Wockhardt is a global pharmaceutical and biotechnology company headquartered in Mumbai, India, announced regulatory approval of two novel antibiotics EMROK (IV) and EMROK O (Oral), for acute bacterial skin and skin structure infections, including diabetic foot infections and concurrent bacteraemia. The new drug target Methicillin resistant Staphylococcus aureus (MRSA), which is a leading cause of rising antimicrobial resistance (AMR).

In September 2021,  Laboratory Corporation of America, is a life sciences company based in the U.S., announced that it had entered into a definitive agreement to acquire select operating assets and intellectual property (IP) from Myriad Genetics, Inc. is genetic testing and precision medicine company based in United States, autoimmune business unit including the methicillin resistant staphylococcus aureus (MRSA) testing systems.